Christina Yap

35PUBLICATIONS
230CO-AUTHORS
Tumour immunologyRadiation therapyMolecular targetsPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Oct 30, 2026
IAP antagonist tolinapant (ASTX660) in combination with pembrolizumab in advanced solid tumors: a phase I trial.

|Oct 01, 2026
Calibration of Priors for Bayesian Model-Based Dose-Finding Trial Designs With Joint Outcomes.

|Apr 30, 2026
PRO-ADD: Patient-empowered dose-finding trials integrating safety, preliminary efficacy and patient-reported outcomes for optimal dose selection.

|Apr 27, 2026
Phase I Trial of Ipatasertib plus Atezolizumab Enhances PI3K/AKT Pathway Immune Responses in Solid Tumors and Refractory Glioblastoma.

|Apr 17, 2026
Generalized Pairwise Comparisons in Dose Optimization Oncology Trials: Beyond Safety to Multi-outcome Dose Selection.

|Jan 23, 2026
International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR.

Emily Alger, Olalekan Lee Aiyegbusi, Amylou C Dueck

Pageof 6

Frequent Collaborators

7 joint publications

Munyaradzi Dimairo

7 joint publications

Johann S de Bono

6 joint publications

Anna Minchom

6 joint publications

Christopher Weir